Doxorubicin: Comparison between 3-h continuous and bolus intravenous administration paradigms on cardio-renal axis, mitochondrial sphingolipids and pathology-Reference-Cited by-同舟云学术

Doxorubicin: Comparison between 3-h continuous and bolus intravenous administration paradigms on cardio-renal axis, mitochondrial sphingolipids and pathology

Published:2015-12 Issue:3 Volume:289 Page:560-572
ISSN:0041-008X
Container-title:Toxicology and Applied Pharmacology
language:en
Short-container-title:Toxicology and Applied Pharmacology

Author:

Kamendi Harriet,Zhou Ying,Crosby Meredith,Keirstead Natalie,Snow Debra,Bentley Patricia^ORCID,Patel Nilaben,Barthlow Herbert,Luo Wenli,Dragan Yvonne,Bialecki Russell

Funder

AstraZeneca

Publisher

Elsevier BV

Subject

Pharmacology,Toxicology

Reference58 articles.

1. QA interval as an indirect measure of cardiac contractility in the conscious telemeterised rat: model optimisation and evaluation;Adeyemi;J. Pharmacol. Toxicol. Methods,2009

2. Do we need additional markers of myocyte necrosis: the potential value of heart fatty-acid-binding protein;Alhadi;QJM,2004

3. Cancer chemotherapy and infusional scheduling;Anderson;Oncology,1994

4. Uncoupling proteins and thermoregulation;Argyropoulos;J. Appl. Physiol.,2002

5. Doxorubicin-induced behavioral disturbances in rats: protective effect of melatonin and captopril;Aziriova;Pharmacol. Biochem. Behav.,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pediatric Cardio-Oncology: Screening, Risk Stratification, and Prevention of Cardiotoxicity Associated with Anthracyclines;Children;2024-07-22

2. Comparison of bolus administration and short-term infusion versus long-term infusion of doxorubicin in terms of cardiotoxicity and efficacy;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-12-14

3. Insights into Doxorubicin-induced Cardiotoxicity: Molecular Mechanisms, Preventive Strategies, and Early Monitoring;Molecular Pharmacology;2019-06-04

4. Toxicological study of a new doxorubicin-loaded pH-sensitive liposome: A preclinical approach;Toxicology and Applied Pharmacology;2018-08

5. The new era of nanotechnology, an alternative to change cancer treatment;Drug Design, Development and Therapy;2017-09